Treasury Moves to Fold Biotech Into China Investment Restrictions
Treasury's October 22 draft rule bans U.S. equity stakes in Chinese biotech firms while carving out licensing deals. Comments close December 7 under the COINS Act.
Topic
Topic
Treasury's October 22 draft rule bans U.S. equity stakes in Chinese biotech firms while carving out licensing deals. Comments close December 7 under the COINS Act.
Treasury proposed a rule restricting US investments over $50,000 in China, Russia and other 'countries of concern,' covering AI,…
IMF chief Kristalina Georgieva says growth "cannot deliver fast enough" as U.S. debt hits $40.3 trillion; Treasury attacks the IM…
Bank of America will pay $1.2bn after admitting it "willfully violated" the Bank Secrecy Act, failing to report over $5bn in susp…
The U.S. Chamber of Commerce is pressing Treasury for swift section 45F guidance covering third-party care intermediaries, resour…